Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Annals of HepatologyOpen Access

Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011–2019

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKwong‐Ming KeeChang Gung UniversityCCChien‐Hung ChenRoyal Columbian HospitalTLTsang‐Wu LiuNational Health Research Institutes

Discussion

Loading...

Member takes

Overview

Analysis shows significant changes in treatment modalities for hepatocellular carcinoma, suggesting improved survival rates over time.

Key Points

  • Survival rates for hepatocellular carcinoma vary significantly, reaching 70% for stage 0 and only 4% for stage D.
  • The highest survival was associated with liver transplantation and surgical resection, impacting treatment preference at various BCLC stages.
  • Data was gathered from the Taiwan Cancer Registry for 73,817 HCC patients to analyze treatment proportions and survival outcomes.
  • The rising proportion of curative treatments suggests a positive trend in survival outcomes for HCC patients in Taiwan.

Cite This Study

Kee et al. (2025) studied this question.

synapsesocial.com/papers/68c1b80c54b1d3bfb60ebc33https://doi.org/10.1016/j.aohep.2025.101943
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 114,700 citations
  2. 2Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan2020 · 114 citations
  3. 3Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update2017 · 2,210 citations
  4. 4Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion2017 · 36 citations
  5. 5Hospital- and Community-Based Screenings for Hepatocellular Carcinoma in Taiwan2011 · 19 citations